BCLS Fund III Investments GP, LLC
- SEC CIK
- 0001952080
In the past year, 2 open-market sale filings worth $115.0M and no purchases.
Current role at each company
- HTFL Heartflow, Inc.10% Owneras of Apr 30, 2026
- NAMS NewAmsterdam Pharma Co N.V.10% Owneras of Dec 17, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $115.0M
- 2 filings
- Net
- −$115.0M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists BCLS Fund III Investments GP, LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
HTFL Heartflow, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 (view filing)8:46 PM ET | Apr 28-30 | 2 days | Bain Capital Life Sciences Investors, LLC and 4 others10% Owner | SSale | −2.00M | $29.45 | −$58.9M | −19.1%8.45M after | 4 lots |
| Feb 6, 2026 (view filing)4:58 PM ET | Feb 4 | 2 days | Bain Capital Life Sciences Investors, LLC and 4 others10% Owner | SSale | −2.00M | $28.05 | −$56.1M | −16.1%10.4M after |
NAMS NewAmsterdam Pharma Co N.V.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2024 (view filing)5:05 PM ET | Dec 13 | 4 days | BCIP Life Sciences Associates, LP and 9 others10% Owner | PPurchase | +1.63M | $24.50 | +$40.0M | –1.63M after | Derivative |